Patient symptoms, confidence, and adherence during the first 8 weeks of targeted oral anticancer agent treatment
Confidence to manage symptoms increased with time on OAAs, but severe symptoms persisted. Although self-reported OAA adherence was high, a notable number of participants reported suboptimal adherence. Relationships between confidence, symptom severity, and adherence should be identified in clinical settings to evaluate patients who may need extra clinical support during OAA treatment.
Authors
- Lauren P. Wallner (ORCID: https://orcid.org/0000-0002-1279-8617)
- Antoinette B. Coe (ORCID: https://orcid.org/0000-0002-5723-0443)
- Christopher R. Friese (ORCID: https://orcid.org/0000-0002-2281-2056)
- Karen B. Farris (ORCID: https://orcid.org/0000-0002-5636-3009)
- Amna Rizvi-Toner (ORCID: https://orcid.org/0009-0005-5407-9070)
- Milisa Manojlovich (ORCID: https://orcid.org/0000-0002-6101-5535)
Institutions
- University of Michigan (US)
- Michigan Medicine (US)
- Michigan Center for Translational Pathology (US)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2026-02-13
- DOI
- https://doi.org/10.1007/s00520-026-10421-7
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 0.00